NDAQ:AUPH - Post Discussion
Post by
whytestocks on Feb 15, 2024 5:30pm
Aurinia Pharmaceuticals Finds No Buyer After Strategic Busin
Just In: $AUPH Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback | BenzingaAurinia Pharmaceuticals Inc (NASDAQ:AUPH) reported a fourth-quarter 2023 EPS loss of $(0.19), missing the consensus of $(0.16) and a bit ...
AUPH - Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback | Benzinga
Be the first to comment on this post